Format

Send to

Choose Destination
Pediatr Infect Dis J. 2014 Aug;33(8):843-5. doi: 10.1097/INF.0000000000000332.

Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy.

Author information

1
From the *Department of Epidemiology, University of Washington, Seattle, WA; †Department of Public Health, University of Nairobi, Nairobi, Kenya; ‡Department of Medicine, University of Washington, Seattle, WA: §Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya; Departments of ¶Global Health and ‖Biostatistics, University of Washington; and **Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Research Center, Seattle, WA.

Abstract

This article describes results from a cross-sectional study among HIV-infected children 15 months to 12 years of age who were receiving antiretroviral therapy. We found a low prevalence of measles IgG seropositivity (45.7%) and identified CD4% ≥ 25 as a predictor. Most HIV-infected children on ART were not measles seropositive and might benefit from revaccination.

PMID:
24618938
PMCID:
PMC4160422
DOI:
10.1097/INF.0000000000000332
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central Icon for Fred Hutchinson Cancer Research Ctr Arnold Library
Loading ...
Support Center